Eisai Co., Ltd. recently announced that its Thai sales subsidiary Eisai (Thailand) Marketing Co., Ltd., (Eisai Thailand) has made an agreement to collaborate with the Department of Medical Services (DMS), Ministry of Public Health (MOPH) of Thailand. Industry sources added that it will aid in boosting access to treatments for dementia including Alzheimer’s disease (AD) in Thailand.
Industry sources added that in Thailand, the number of people suffering from dementia is expected to surge from the current 700 thousand to 2 million by 2050 due to the rapid aging of the population. Dementia and AD are the third leading cause of death among women (7.1% of total deaths) and the ninth leading cause of death for men (3.3% of total deaths).
This has in turn made the requirement to build a system to counter dementia urgent. Industry sources added that with this agreement, Eisai Thailand and DMS have identified three vital hurdles in addressing issues regarding dementia and AD in Thailand: (1) raising disease awareness for Mild Cognitive Impairment (MCI) and dementia including AD (2) improving diagnosis infrastructure for MCI and dementia including AD and ensuring civilian access to these services (3) ensuring total care by building a dementia community and ecosystem for people with dementia and their families.
Eisai will lead to support people with dementia and their families to “live their fullest lives” to effectively achieve social good in the form of “relieving anxiety over health” and “reducing health disparities”.
Industry sources added that the formulation of disease guidelines by the state is essential to address these challenges. Eisai Thailand and DMS will jointly conduct surveys and other initiatives to establish such guidelines. Additionally, both organizations will promote the implementation of these guidelines in collaboration with various stakeholders, including those from different industries, to develop an ecosystem dedicated to dementia, seeking to establish a strong support system for the dementia community in Thailand.
Interested to gain more information regarding healthcare and information on healthcare experts? Then please visit these links:
Kilo Health Experts Reveal Health Tech Trends that Are Changing the World
Quanterix launches LucentAD biomarker test to aid early Diagnosis of Alzheimer’s Disease
